Weighted average lithium value in first three batches of drill core samples exceeds the average lithium value of previously reported surface samples by 72%

VANCOUVER, BC / ACCESSWIRE / March 23, 2017 / Noram Ventures Inc. (TSX-Venture: NRM / Frankfurt: N7R / OTC PINK: NRVTF) (“Noram”) and Alba Minerals Ltd. (“Alba”) (TSX-V: AA.H / OTC PINK: AXVEF) are pleased to announce the third batch of drill core sample results from the 46-hole Phase I drilling program that focused on the Zeus portion of their Clayton Valley Lithium Project in Nevada (see Figure 1). The Zeus claims are located within two kilometers (1.25 miles) of Albemarle’s Silver Peak Lithium Mine that has been in production since 1966 and is the only lithium-brine production operation in North America.

The third group of 10 holes reported herein consisted of 132.4 meters (434 feet) of core drilling with an average hole depth of 13.2 meters (43.4 feet) and core sampling done primarily on 1.22 meter (4-foot) intervals. Bradley C. Peek, MSc and Certified Professional Geologist supervised the collection of the cores and samples; and sample analysis was performed by ALS Labs (Reno, NV) on 111 samples from the 10 holes using a 4-acid digestion and MS-ICP methods for 48 elements.

Table 1 lists each drill hole’s location (NAD 83, Zone 11S), elevation and depth – all in meters. All holes were vertical. All core size was BQ.

Table 1 – Drill Hole Location Information

Hole ID

UTM Easting

UTM Northing

Approx. Elev.

Depth

Dip

CVZ-21

455961.7

4180720.2

1341

15.2

-90

CVZ-22

455926.0

4180650.8

1342

12.2

-90

CVZ-23

455837.3

4180785.9

1338

13.7

-90

CVZ-24

456031.3

4180594.5

1346

15.2

-90

CVZ-25

455780.8

4181171.1

1331

15.2

-90

CVZ-26

455479.0

4180533.1

1328

15.5

-90

CVZ-27

455504.0

4180452.5

1331

6.7

-90

CVZ-28

455814.5

4180544.1

1342

14.9

-90

CVZ-29

455129.8

4180984.9

1316

12.2

-90

CVZ-30

455421.0

4180593.0

1327

15.2

-90

All but two of these drill holes are all located in an area of close-spaced drilling measuring approximately 800 meters (2,600 feet) by 520 meters (1,700 feet)(see Figure 2). Lithium values continue to be very consistent across the close-spaced drilling area.

Table 2 lists the samples, their intervals, their weights and their lithium analytical results. The core holes were vertical and the sedimentary units that were tested are horizontal or dipping at less than 5º, so the intervals sampled are true widths.

Hole
ID

Sample
ID

Sample Wt.
(kg)

From
(ft)

To
(ft)

From
(m)

To
(m)

Li
(ppm)

CVZ-21

289737

0.58

0

4

0.00

1.22

1630

CVZ-21

289738

0.92

4

8

1.22

2.44

1740

CVZ-21

289739

0.82

8

12

2.44

3.66

1930

CVZ-21

289740

0.70

12

16

3.66

4.88

1520

CVZ-21

289741

0.86

16

20

4.88

6.10

1580

CVZ-21

289742

0.86

20

24

6.10

7.32

1190

CVZ-21

289743

0.98

24

28

7.32

8.53

1120

CVZ-21

289744

0.76

28

32

8.53

9.75

1160

CVZ-21

289745

0.80

32

36

9.75

10.97

880

CVZ-21

289746

1.10

36

40

10.97

12.19

980

CVZ-21

289747

0.84

40

44

12.19

13.41

1170

CVZ-21

289748

0.84

44

48

13.41

14.63

970

CVZ-21

289749

0.30

48

50

14.63

15.24

1000

CVZ-22

289765

0.58

4

8

1.22

2.44

1080

CVZ-22

289766

0.84

8

12

2.44

3.66

1310

CVZ-22

289767

0.68

12

16

3.66

4.88

1380

CVZ-22

289768

0.68

16

20

4.88

6.10

1480

CVZ-22

289769

0.78

20

24

6.10

7.32

1640

CVZ-22

289770

0.60

24

28

7.32

8.53

1680

CVZ-22

289771

0.72

28

32

8.53

9.75

1340

CVZ-22

289772

0.68

32

36

9.75

10.97

1210

CVZ-22

289773

0.68

36

40

10.97

12.19

1070

CVZ-23

289725

0.36

0

4

0.00

1.22

1540

CVZ-23

289726

0.56

4

8

1.22

2.44

810

CVZ-23

289727

0.62

8

12

2.44

3.66

1030

CVZ-23

289728

0.58

12

16

3.66

4.88

940

CVZ-23

289729

0.52

16

20

4.88

6.10

950

CVZ-23

289730

0.54

20

24

6.10

7.32

990

CVZ-23

289731

0.52

24

28

7.32

8.53

1170

CVZ-23

289732

0.78

28

32

8.53

9.75

1300

CVZ-23

289733

0.74

32

36

9.75

10.97

930

CVZ-23

289734

0.62

36

40

10.97

12.19

970

CVZ-23

289735

0.74

40

45

12.19

13.72

850

CVZ-24

289751

0.42

0

4

0.00

1.22

680

CVZ-24

289752

1.00

4

8

1.22

2.44

900

CVZ-24

289753

0.94

8

12

2.44

3.66

1670

CVZ-24

289754

1.04

12

16

3.66

4.88

2340

CVZ-24

289755

0.84

16

20

4.88

6.10

1060

CVZ-24

289756

0.50

20

24

6.10

7.32

890

CVZ-24

289757

1.14

24

28

7.32

8.53

870

CVZ-24

289758

0.86

28

32

8.53

9.75

1010

CVZ-24

289760

0.94

32

36

9.75

10.97

1000

CVZ-24

289761

0.76

36

40

10.97

12.19

1550

CVZ-24

289762

0.74

40

44

12.19

13.41

1190

CVZ-24

289763

0.32

44

48

13.41

14.63

1330

CVZ-24

289764

0.28

48

50

14.63

15.24

1520

CVZ-25

289813

0.20

0

4

0.00

1.22

426

CVZ-25

289814

0.86

4

8

1.22

2.44

810

CVZ-25

289815

0.76

8

12

2.44

3.66

670

CVZ-25

289816

0.82

12

16

3.66

4.88

590

CVZ-25

289817

0.86

16

20

4.88

6.10

670

CVZ-25

289818

0.76

20

24

6.10

7.32

680

CVZ-25

289819

0.82

24

28

7.32

8.53

480

CVZ-25

289820

0.74

28

32

8.53

9.75

500

CVZ-25

289821

0.92

32

36

9.75

10.97

520

CVZ-25

289822

0.60

36

40

10.97

12.19

860

CVZ-25

289824

0.54

40

42

12.19

12.80

448

CVZ-26

289875

0.22

0

4

0.00

1.22

1520

CVZ-26

289876

0.62

4

8

1.22

2.44

1200

CVZ-26

289877

0.54

8

12

2.44

3.66

1260

CVZ-26

289878

0.62

12

16

3.66

4.88

960

CVZ-26

289879

0.50

16

20

4.88

6.10

880

CVZ-26

289880

0.66

20

24

6.10

7.32

920

CVZ-26

289881

0.48

24

28

7.32

8.53

740

CVZ-26

289882

0.74

28

32

8.53

9.75

730

CVZ-26

289883

0.80

32

36

9.75

10.97

980

CVZ-26

289884

0.86

36

40

10.97

12.19

800

CVZ-26

289885

0.80

40

44

12.19

13.41

860

CVZ-26

289886

0.58

44

48

13.41

14.63

960

CVZ-26

289887

0.64

48

51

14.63

15.54

750

CVZ-27

289889

0.28

0

4

0.00

1.22

1150

CVZ-27

289890

0.34

4

8

1.22

2.44

1380

CVZ-27

289891

0.34

8

12

2.44

3.66

1060

CVZ-27

289892

0.82

12

16

3.66

4.88

1350

CVZ-27

289893

0.62

16

20

4.88

6.10

1000

CVZ-27

289894

0.42

20

21.7

6.10

6.61

800

CVZ-28

289825

0.50

0

4

0.00

1.22

1270

CVZ-28

289826

0.62

4

8

1.22

2.44

1160

CVZ-28

289827

1.08

8

12

2.44

3.66

1400

CVZ-28

289828

1.02

12

16

3.66

4.88

1450

CVZ-28

289829

0.88

16

20

4.88

6.10

1680

CVZ-28

289830

0.90

20

24

6.10

7.32

1340

CVZ-28

289831

0.86

24

28

7.32

8.53

1270

CVZ-28

289832

0.86

28

32

8.53

9.75

1130

CVZ-28

289833

0.58

32

36

9.75

10.97

830

CVZ-28

289834

0.90

36

40

10.97

12.19

1050

CVZ-28

289835

0.66

40

44

12.19

13.41

930

CVZ-28

289836

0.86

44

48.8

13.41

14.87

1010

CVZ-29

289909

0.28

0

4

0.00

1.22

770

CVZ-29

289910

1.00

4

8

1.22

2.44

1010

CVZ-29

289911

1.06

8

12

2.44

3.66

1390

CVZ-29

289912

0.94

12

16

3.66

4.88

1670

CVZ-29

289913

0.94

16

20

4.88

6.10

1940

CVZ-29

289914

0.80

20

24

6.10

7.32

1320

CVZ-29

289915

0.88

24

28

7.32

8.53

900

CVZ-29

289916

1.00

28

32

8.53

9.75

880

CVZ-29

289917

0.94

32

36

9.75

10.97

880

CVZ-29

289918

0.70

36

40

10.97

12.19

870

CVZ-30

289799

0.36

0

4

0.00

1.22

1080

CVZ-30

289800

0.78

4

8

1.22

2.44

820

CVZ-30

289801

0.56

8

12

2.44

3.66

810

CVZ-30

289802

0.68

12

16

3.66

4.88

960

CVZ-30

289803

0.52

16

20

4.88

6.10

840

CVZ-30

289804

0.90

20

24

6.10

7.32

770

CVZ-30

289805

0.64

24

28

7.32

8.53

840

CVZ-30

289806

0.48

28

32

8.53

9.75

790

CVZ-30

289807

0.56

32

36

9.75

10.97

670

CVZ-30

289808

0.76

36

40

10.97

12.19

800

CVZ-30

289809

0.64

40

44

12.19

13.41

500

CVZ-30

289810

0.36

44

48

13.41

14.63

480

CVZ-30

289811

0.18

48

50

14.63

15.24

425

Sample intervals were split by geologists at the drilling program staging area. Half of the core was retained in the core boxes for future review and/or sampling. The other half was securely sent to ALS Laboratories in Reno, Nevada, USA for testing. Core recovery for these third 10 core holes averaged 80.3%.

The lithium content of the 111 samples had an interval-weighted average of 1,072.6 ppm with a minimum value of 425 ppm and a maximum value of 2,340 ppm. The maximum value was over a 1.22m (4 ft) intersection, while the minimum value was over a 0.61m (2 ft) interval. The samples had a median value of 1000 ppm Li. Collectively, the weighted average lithium value in first three batches of drill core samples exceeds the average value of previously reported surface samples by 72% when comparing the weighted average of the first 30 holes (1,066 ppm Li) to the average of the 77 surface samples (621 ppm Li).

Laboratory standards with two different lithium ranges (1,237 ppm and 783 ppm) were inserted into the sample stream, along with lithium blanks and duplicate samples (10 QA/QC samples, in all, with these samples). The standards and blanks were obtained from MEG Labs of Reno, Nevada, USA. Duplicate samples were obtained by splitting the remaining half of the split core (1/4 of the original core). All analyses of the standards, blanks and duplicates were well within acceptable ranges.

“The lithium values continue to be consistent, both vertically and horizontally, across all 30 holes we have reported to date,” said Mark Ireton President and CEO of Noram. These continued positive results are supporting our near term goals, which includes on site bulk sampling testing, and in-fill core drilling. Phase 2 drilling program would encompass the Spartan claims, in addition to drilling along the outer boundaries of the contiguous properties, to determine lithium content property wide.

Analytical results from the remaining 16 drill holes of the Phase 1 drilling program are pending.

Noram is amassing one of the largest land packages in Nevada’s Clayton Valley. Its non-contiguous North and South Blocks now total 888 claims covering 17,738 acres and are positioned both north and south of Albemarle’s Silver Peak mine, North America’s only lithium producer.

The technical information contained in this news release has been reviewed and approved by Bradley C. Peek, MSc and Certified Professional Geologist, who is a Qualified Person with respect to Noram’s Clayton Valley Lithium Project as defined under National Instrument 43-101.

About Noram Ventures Inc.:

Noram Ventures Inc. (TSX-Venture: NRM / Frankfurt: N7R / OTCBB: NRVTF) is a Canadian based junior exploration company, with a goal of becoming a force in the Green Energy Revolution through the development of lithium and graphite deposits and becoming a low-cost supplier for the burgeoning lithium battery industry. The Company’s primary business focus since formation has been the exploration of mineral properties. Current projects include lithium properties in the Clayton Valley of Nevada and the Hector Lode in San Bernardino County, California; and the Jumbo graphite property in southeastern British Columbia. Noram’s long term strategy is to build a multi-national lithium-graphite dominant industrial minerals company to produce and sell lithium and graphite into the markets of Europe, North America and Asia.

Please visit our web site for further information: www.noramventures.com.

ON BEHALF OF THE BOARD OF DIRECTORS

/s/ “Mark R. Ireton”

President & Director
Noram Ventures Inc.

This news release contains projections and forward-looking information that involve various risks and uncertainties regarding future events. Such forward-looking information can include without limitation statements based on current expectations involving a number of risks and uncertainties and are not guarantees of future performance of the Company. The following are important factors that could cause the Company’s actual results to differ materially from those expressed or implied by such forward looking statements; the uncertainty of future profitability; and the uncertainty of access to additional capital. These risks and uncertainties could cause actual results and the Company’s plans and objectives to differ materially from those expressed in the forward-looking information. Actual results and future events could differ materially from anticipated in such information. These and all subsequent written and oral forward-looking information are based on estimates and opinions of management on the dates they are made and expressed qualified in their entirety by this notice. The Company assumes no obligation to update forward-looking information should circumstance or management’s estimates or opinions change.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE: Noram Ventures Inc.

ReleaseID: 458039

LOS ANGELES, CA / ACCESSWIRE / March 23, 2017 / Lundin Law PC, a shareholder rights firm, announces the filing of a class action lawsuit against PixarBio Corporation (“PixarBio” or the “Company”) (OTC PINK: PXRB) concerning possible violations of federal securities laws between October 31, 2016 and January 20, 2017, inclusive (the “Class Period”). Investors, who purchased or otherwise acquired shares during the Class Period should contact the firm prior to the March 27, 2017 lead plaintiff motion deadline.

To participate in this class action lawsuit, click here. You can also call Brian Lundin, Esquire, of Lundin Law PC, at 888-713-1033, or e-mail him at brian@lundinlawpc.com.

No class has been certified in the above action. Until a class is certified, you are not considered represented by an attorney. You may also choose to do nothing and be an absent class member.

On January 23, 2017, the SEC revealed the temporary suspension of trading in the stocks of PixarBio “because the market for the security appears to reflect manipulative or deceptive activities and because of questions regarding the accuracy of assertions by PixarBio in press releases and its Form S-1 concerning, among other things: (1) the company’s business combinations and current shareholders; (2) the identity and qualifications of key shareholders and employees; and (3) the company’s current and prospective development efforts.” When this news was released to the public, the value of PixarBio dropped, causing investors harm.

Lundin Law PC was founded by Brian Lundin, a securities litigator based in Los Angeles dedicated to upholding shareholders’ rights.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contact:

Lundin Law PC

Brian Lundin, Esq.

Telephone: 888-713-1033

Facsimile: 888-713-1125

brian@lundinlawpc.com

http://lundinlawpc.com/

SOURCE: Lundin Law PC

ReleaseID: 458029

LOS ANGELES, CA / ACCESSWIRE / March 23, 2017 / Lundin Law PC, a shareholder rights firm, announces the filing of a class action lawsuit against Innocoll Holdings plc (“Innocoll” or the “Company”) (NASDAQ: INNL) concerning possible violations of federal securities laws between March 17, 2016 and December 29, 2016, inclusive (the “Class Period”). Investors, who purchased or otherwise acquired shares during the Class Period, should contact the firm prior to the March 27, 2017 lead plaintiff motion deadline.

To participate in this class action lawsuit, click here. You can also call Brian Lundin, Esquire, of Lundin Law PC, at 888-713-1033, or e-mail him at brian@lundinlawpc.com.

No class has been certified in the above action. Until a class is certified, you are not considered represented by an attorney. You may also choose to do nothing and be an absent class member.

According to the Complaint, Innocoll failed to disclose that it’s New Drug Application submission to the U.S. Food and Drug Administration in October 2016 for XARACOLL was unsuccessful and because of this, XARACOLL could not be approved in 2017. Innocoll then received a Refusal to File letter from the FDA. When this information was announced to the public, the value of Innocoll stock dropped, causing shareholders harm.

Lundin Law PC was founded by Brian Lundin, a securities litigator based in Los Angeles dedicated to upholding shareholders’ rights.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contact:

Lundin Law PC
Brian Lundin, Esq.
Telephone: 888-713-1033
Facsimile: 888-713-1125
brian@lundinlawpc.com
http://lundinlawpc.com/

SOURCE: Lundin Law PC

ReleaseID: 458028

RADNOR, PA / ACCESSWIRE / March 23, 2017 / The law firm of Kessler Topaz Meltzer & Check, LLP announces that a class action lawsuit has been filed against Roadrunner Transportation Systems, Inc. (NYSE: RRTS) (“Roadrunner” or the “Company”) on behalf of purchasers of the Company’s securities between
May 8, 2014 and January 30, 2017, inclusive (the “Class Period”).

Roadrunner shareholders may, no later than April 3, 2017, seek to be appointed as a lead plaintiff of the class. For additional information, or to learn how to participate in this action, please visit https://www.ktmc.com/new-cases/roadrunner-transportation-systems-inc#join.

Shareholders who wish to discuss this action and their legal options are encouraged to contact Kessler Topaz Meltzer & Check (Darren J. Check, Esq., D. Seamus Kaskela, Esq. or Adrienne O. Bell, Esq.) at (888) 299 – 7706 or (610) 667 – 7706, or via e-mail at info@ktmc.com.

Roadrunner offers truck freight transportation services. The Company operates through three segments: Truckload Logistics, Less-than-Truckload, and Global Solutions.

The shareholder class action complaint alleges that Roadrunner and certain of its executive officers made a series of materially false and misleading statements and/or failed to disclose material adverse facts about the Company’s business, operations, and prospects to investors during the Class Period. Specifically, the defendants are alleged to have made false and misleading statements and/or failed to disclose that: (1) the Company lacked effective internal controls over financial reporting; (2) the Company’s financial statements dating back to the beginning of 2014 overstated the estimated results of operations; (3) the Company’s financial statements contained errors relating to unrecorded expenses from unreconciled balance sheet accounts including cash, driver and other receivables, and linehaul and other driver payables; and (4) the Company’s financial statements dating back to the beginning of 2014 were not reliable.

On January 30, 2017, Roadrunner disclosed that, as a result of “nformation obtained to date in connection with an ongoing investigation” into the Company’s accounting, certain of Roadrunner’s previously issued financial statements should no longer be relied upon due to misstatements. Additionally, the Company reported that “Roadrunner has identified various accounting errors that it currently estimates will require prior period adjustments to Roadrunner’s results of operations of between $20 million and $25 million.” Further, Roadrunner reported that it would need to record a goodwill impairment charge, estimated “in the range of $175 million to $200 million,” in its upcoming quarterly financial report.

On this news, shares of the Company’s stock fell $3.62 per share, or over 31%, to close on January 31, 2017 at $7.92 per share, on unusually heavy trading volume.

Roadrunner shareholders may, no later than April 3, 2017, petition the Court to be appointed as a lead plaintiff representative of the class through Kessler Topaz Meltzer & Check or other counsel, or may choose to do nothing and remain an absent class member. A lead plaintiff is a representative party who acts on behalf of all class members in directing the litigation. In order to be appointed as a lead plaintiff, the Court must determine that the class member’s claim is typical of the claims of other class members, and that the class member will adequately represent the class in the action. Your ability to share in any recovery is not affected by the decision of whether or not to serve as a lead plaintiff. For additional information, or to learn how to participate in this action, please visit https://www.ktmc.com/new-cases/roadrunner-transportation-systems-inc#join.

Kessler Topaz Meltzer & Check prosecutes class actions in state and federal courts throughout the country. Kessler Topaz Meltzer & Check is a driving force behind corporate governance reform, and has recovered billions of dollars on behalf of institutional and individual investors from the United States and around the world. The firm represents investors, consumers, and whistleblowers (private citizens who report fraudulent practices against the government and share in the recovery of government dollars). The complaint in this action was not filed by Kessler Topaz Meltzer & Check. For more information about Kessler Topaz Meltzer & Check, please visit www.ktmc.com.

CONTACT:

Kessler Topaz Meltzer & Check, LLP
Darren J. Check, Esq.
D. Seamus Kaskela, Esq.
Adrienne O. Bell, Esq.
280 King of Prussia Road
Radnor, PA 19087
(888) 299-7706
(610) 667-7706
info@ktmc.com

SOURCE: Kessler Topaz Meltzer & Check, LLP

ReleaseID: 454171

IRVINE, CA / ACCESSWIRE / March 23, 2017 / Khang & Khang LLP (the “Firm”) announces the filing of a class action lawsuit against Vista Outdoor, Inc. (“Vista” or the “Company”) (NYSE: VSTO). Investors, who purchased or otherwise acquired Vista shares between August 11, 2016, and January 13, 2017, inclusive (the “Class Period”), are encouraged to contact the firm in advance of the March 27, 2017 lead plaintiff deadline.

If you purchased shares of Vista during the Class Period, please contact Joon M. Khang, Esquire, of Khang & Khang, 18101 Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone: (949) 419-3834, or via e-mail at joon@khanglaw.com.

There has been no class certification in this case. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member.

On January 12, 2017, Vista revealed that it expects a material asset impairment charge (approximately $400 – $450 million) due to its Hunting and Shooting Accessories reporting unit during the third quarter of the 2017 fiscal year. When this news was announced, the value of Vista fell over 21% that day. On January 13, 2017, Vista stated that the President of its Outdoor Products segment, in which the Hunting and Shooting Accessories unit belongs, had left his position.

When this information was revealed to the investing public, the value of Vista declined, causing investors harm.

If you wish to learn more about this lawsuit, at no charge, or if you have questions concerning this notice or your rights, please contact Joon M. Khang, a prominent litigator for almost two decades, by telephone: (949) 419-3834, or via e-mail at joon@khanglaw.com.

This press release may constitute Attorney Advertising in some jurisdictions.

Contact:

Joon M. Khang, Esq.

Telephone: 949-419-3834

Facsimile: 949-225-4474

joon@khanglaw.com

SOURCE: Khang & Khang LLP

ReleaseID: 458024

NEW YORK, NY / ACCESSWIRE / March 23, 2017 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Aratana Therapeutics, Inc. (“Aratana” or the “Company”) (NASDAQ: PETX) and certain of its officers, on behalf of a class who purchased Aratana securities between March 16, 2015 and February 3, 2017, inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: www.bgandg.com/petx.

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.

The Complaint alleges that throughout the Class Period, Defendants made false and/or misleading statements and/or failed to disclose that: (1) Aratana did not have adequate manufacturing contracts in place to upkeep manufacturing of ENTYCE at a commercial scale; (2) therefore, ENTYCE was not likely to be commercially available until late 2017; (3) accordingly, Aratana had misled investors regarding the probable timeline for a commercial launch of ENTYCE; and (4) consequently, Aratana’s public statements were materially false and misleading at all relevant times.

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint, you can visit the firm’s site: www.bgandg.com/petx or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in Aratana, you have until April 7, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:

Bronstein, Gewirtz & Grossman, LLC

Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC

ReleaseID: 454528

NEW YORK, NY / ACCESSWIRE / March 23, 2017 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Galena Biopharma, Inc. (“Galena” or the “Company”) (NASDAQ: GALE) and certain of its officers, and is on behalf of purchasers of Galena securities from August 11, 2014 through January 31, 2017, inclusive (the “Class Period”). Such investors are advised to join this case by visiting the firm’s site: http://www.bgandg.com/gale.

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the “Exchange Act”).

The Complaint alleges that throughout the Class Period, Defendants made false and/or misleading statements and/or failed to disclose that: (1) Galena’s sales of Abstral were based on unsustainable sales and marketing practices; (2) such sales and marketing practices could subject Galena to a criminal investigation; and (3) consequently, Galena’s statements about its business, operations, and prospects were false and misleading and/or lacked a reasonable basis.

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint, you can visit the firm’s site: http://www.bgandg.com/gale, or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in Galena, you have until April 14, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:

Bronstein, Gewirtz & Grossman, LLC

Peretz Bronstein or Yael Hurwitz

212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC

ReleaseID: 454995